These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3199812)
1. Aromatase-inhibitors of the androstenedione-type activate the 17 beta-hydroxysteroid-dehydrogenase in the rat testis tissue suspension model. Schröder H; Ziegler M; el Etreby MF J Steroid Biochem; 1988 Oct; 31(4B):685-90. PubMed ID: 3199812 [TBL] [Abstract][Full Text] [Related]
2. Enzyme interactions of 2,10-ethanoandrostene-3,17-dione: aromatase and 17 beta-hydroxysteroid dehydrogenase. Greway AT; Mentzer M; Levy MA Biochem Int; 1990; 20(3):591-7. PubMed ID: 2161228 [TBL] [Abstract][Full Text] [Related]
3. Gonadal in vitro androstenedione metabolism and changes in some plasma and gonadal steroid hormones during sex inversion of the protandrous sea bass, Lates calcarifer. Guiguen Y; Jalabert B; Benett A; Fostier A Gen Comp Endocrinol; 1995 Oct; 100(1):106-18. PubMed ID: 8575651 [TBL] [Abstract][Full Text] [Related]
4. A further study of 17 beta-hydroxysteroid oxidoreductase in the human testis: mechanism of in vitro activation. Oshima H; Yoshida K; Troen P Endocrinol Jpn; 1980 Feb; 27(1):107-15. PubMed ID: 6248333 [TBL] [Abstract][Full Text] [Related]
5. Cellular regulation of the metabolism of androgens in rat oral mucosa. II. Product activation of 17 beta-hydroxysteroid oxidoreductase enzyme system. Vittek J; Gordon GG; Rappaport SC; Southren AL J Dent Res; 1979 Feb; 58(2):638-41. PubMed ID: 283095 [TBL] [Abstract][Full Text] [Related]
6. Androgen inactivation in human lung fibroblasts: variations in levels of 17 beta-hydroxysteroid dehydrogenase type 2 and 5 alpha-reductase activity compatible with androgen inactivation. Provost PR; Blomquist CH; Drolet R; Flamand N; Tremblay Y J Clin Endocrinol Metab; 2002 Aug; 87(8):3883-92. PubMed ID: 12161528 [TBL] [Abstract][Full Text] [Related]
7. In vitro studies on the inhibition of testosterone synthesis in the human testis by atamestane. Lombardo ME; Hakky SI; Hudson PB J Steroid Biochem Mol Biol; 1993 Mar; 44(3):287-90. PubMed ID: 8384873 [TBL] [Abstract][Full Text] [Related]
8. Relationship between the structures and steroidogenic functions of the testes of the urohaze-goby (Glossogobius olivaceus). Asahina K; Suzuki K; Aida K; Hibiya T; Tamaoki B Gen Comp Endocrinol; 1985 Feb; 57(2):281-92. PubMed ID: 3156787 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments. Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056 [TBL] [Abstract][Full Text] [Related]
10. Effect of 1,4,6-androstatriene-3,17-dione (ATD), 4-hydroxy-4-androstene-3,17-dione (4-OH-A) and 4-acetoxy-4-androstene-3,17-dione (4-Ac-A) on the 5 alpha-reduction of androgens in the rat prostate. Motta M; Zoppi S; Brodie AM; Martini L J Steroid Biochem; 1986 Oct; 25(4):593-600. PubMed ID: 3773531 [TBL] [Abstract][Full Text] [Related]
11. Studies of the human testis. VIII. Product activation of 17beta-hydroxysteroid oxidoreductase for testosterone. Oshima H; Paraska L; Yoshida KI; Troen P J Clin Endocrinol Metab; 1977 Nov; 45(5):1097-9. PubMed ID: 21887 [TBL] [Abstract][Full Text] [Related]
12. Mammary steroidogenesis: therapeutic implications. Miller WR; O'Neill J Int J Rad Appl Instrum B; 1987; 14(4):369-75. PubMed ID: 3477535 [No Abstract] [Full Text] [Related]
13. In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3. Roy J; Fournier MA; Maltais R; Kenmogne LC; Poirier D J Steroid Biochem Mol Biol; 2014 May; 141():44-51. PubMed ID: 24434282 [TBL] [Abstract][Full Text] [Related]
14. Differential regulation of steroidogenic enzymes metabolizing testosterone or dihydrotestosterone by human chorionic gonadotropin in cultured rat neonatal interstitial cells. Murono EP Acta Endocrinol (Copenh); 1990 Mar; 122(3):289-95. PubMed ID: 2158194 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione. Brodie AM; Longcope C Endocrinology; 1980 Jan; 106(1):19-21. PubMed ID: 6765930 [TBL] [Abstract][Full Text] [Related]
16. Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism. Brodie AM; Son C; King DA; Meyer KM; Inkster SE Cancer Res; 1989 Dec; 49(23):6551-5. PubMed ID: 2479464 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. Dufort I; Rheault P; Huang XF; Soucy P; Luu-The V Endocrinology; 1999 Feb; 140(2):568-74. PubMed ID: 9927279 [TBL] [Abstract][Full Text] [Related]
18. 19-oxygenated derivatives of androst-4-ene-6,17-dione and androst-5-ene-4,17-dione as catalytic probes for the active site of aromatase. Numazawa M; Yamada K; Kidokoro K Biol Pharm Bull; 1999 Oct; 22(10):1134-6. PubMed ID: 10549872 [TBL] [Abstract][Full Text] [Related]
19. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962). Johnston JO; Wright CL; Holbert GW; Benson HD J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520 [TBL] [Abstract][Full Text] [Related]